Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication
Archives of The Medicine and Case Reports – October 13, 2021
Source: OpenAlex
Summary
Consuming Psilocybe mushrooms, containing the hallucinogen Psilocybin, can induce severe psychological and life-threatening physical distress. A single case details a 22-year-old male experiencing disorientation, auditory hallucinations, and bizarre movements, necessitating psychiatric care. This acute event, similar to Mescaline intoxication, also caused life-threatening kidney injury. Such incidents underscore critical safety concerns in Psychedelics and Drug Studies, often overlooked amidst discussions of Pain Management or the Placebo Effect. This aspect of Psychology and Psychiatry highlights the dark side of substances that can lead to experiences sometimes interpreted as paranormal.
Abstract
Introduction. Psilocybe mushroom, or wi dely known as the magic mushroom is a variety of mushroom commonly consumed because of hallucinogenic traits it causes toward its consumer. This hallucinogenic effect is caused by Psilocybin, a hallucinogenic substance often found within Psilocybe mushroom. This substance affects mental state of the consumer and has similar effect to those of LSD and Mescaline. Aside from its effect to cause mental disturbance, consumption of this mushroom may cause acute renal injury which leads to a fatal and life -threatening situation. Case presentation. A case of Psilocybe intoxication had been reported in a 22 years old male with a confirmed history of consuming Psilocybe mushroom. Patient first came with a symptom of disorientation and restlessness. Patient also often shook his head off, laughed out, screamed, and continuously making bizarre movements. Psychiatric examination confirmed a sign of auditory hallucination, unstable mood, and stereotypical behavior experienced by the patient. Conclusion. An approach is needed in the form of a ph ysical examination and support that supports a prompt and precise diagnosis, as well as comprehensive management that focuses on the direct management of life-threatening symptoms and symptomatic treatment, taking into account the si gns and symptoms of life-threateningnephrotoxicity